PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | C0019196|hepatitis c |
| Sentences | 119 |
| PubMedID- 25469280 | Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis c virus infection: a prospective study. |
| PubMedID- 21374690 | Previous studies have suggested that prior exposure to hepatitis b virus (hbv) infection may increase the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 19879972 | Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related cirrhosis. |
| PubMedID- 23404391 | Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis c: report of a case. |
| PubMedID- 25654412 | Results: there were 109 patients with hepatocellular carcinoma associated with hepatitis c virus that underwent living-donor liver transplant from july 2002 to june 2012. |
| PubMedID- 26446006 | Background and objectives: we studied the effect of achieving sustained virological response (svr) on the risk of developing hepatocellular carcinoma (hcc) in patients with hepatitis c receiving anti-hepatitis c virus treatment. |
| PubMedID- 22105231 | Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis c virus infection receiving interferon therapy: a single center study. |
| PubMedID- 26045707 | Conclusions: sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c. |
| PubMedID- 22588449 | Skull metastasis from hepatocellular carcinoma with hepatitis c. |
| PubMedID- 21278701 | The incidence of hepatocellular carcinoma associated with hepatitis c infection decreased in kyushu area. |
| PubMedID- 21820396 | Background & aims: hepatocellular carcinoma (hcc) can result from hepatitis c virus (hcv)-related liver disease and is the fastest-growing cause of cancer-related death in the united states. |
| PubMedID- 22096937 | [antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis]. |
| PubMedID- 24393884 | Case 1 involved a 63-year-old woman who had multiple hepatocellular carcinomas (hcc) associated with hepatitis c virus infection. |
| PubMedID- 21461077 | Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated. |
| PubMedID- 23122451 | Is serum level of methylated rassf1a valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis c. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 21286221 | A 72-year-old japanese man underwent partial resection of the liver for hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 22555181 | A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis c or b: a novel approach by using meta-regression. |
| PubMedID- 24367218 | Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus. |
| PubMedID- 21563203 | Inactivation of klf6 is common in hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection, thereby abrogating its normal antiproliferative activity in liver cells. |
| PubMedID- 25331666 | [increased risk of hepatocellular carcinoma in patients with chronic hepatitis c.] |
| PubMedID- 25743000 | Objective: to determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (hcc) in patients with hepatitis c. |
| PubMedID- 22957141 | End-stage liver diseases as well as hepatocellular carcinoma attributable to chronic hepatitis c are increasingly serious problems2. |
| PubMedID- 20616578 | Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus. |
| PubMedID- 22414050 | Aim: the role of interferon (ifn) therapy on prevention of hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv)-related cirrhosis remains controversial. |
| PubMedID- 22207106 | Randomized controlled trials also confirm that glycyrrhizin and its derivatives can improve the hepatocellular injury in chronic hepatitis b or c patients, and reduce the risk for hepatocellular carcinoma in patients with hepatitis c virus-induced cirrhosis [12]. |
| PubMedID- 24409059 | Latent hepatitis b is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 23657093 | Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death [2]. |
| PubMedID- 23065464 | Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects. |
| PubMedID- 26070204 | Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response. |
| PubMedID- 21499248 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2,890 hcv-negative controls of japanese origin. |
| PubMedID- 22044490 | Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. |
| PubMedID- 22875473 | Inhibition of hepatocellular carcinoma by pegifnalpha-2a in patients with chronic hepatitis c: a nationwide multicenter cooperative study. |
| PubMedID- 23509319 | Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 24632756 | The serum level of vegf has potential to be a useful predictor of the presence of hepatocellular carcinoma in patients with hepatitis c virus (hcv)-related liver cirrhosis, while serum levels of afp and vegf can predict tumor type and vascular invasion, respectively25. |
| PubMedID- 24463696 | Influence of human t-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 20521755 | The american association for the study of liver diseases recommends ultrasound surveillance for hepatocellular carcinoma in persons with chronic hepatitis c virus infection and cirrhosis. |
| PubMedID- 21056500 | Background & aims: evidence on the efficacy of antiviral treatment in chronic hepatitis c (chc) patients with hepatocellular carcinoma (hcc) after curative treatment is scarce. |
| PubMedID- 24223115 | The progression of hepatic fibrosis is an important predictive factor for the development of lc and hepatocellular carcinoma not only in patients with chronic hepatitis c, but also in those with nash [4]. |
| PubMedID- 24462733 | A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis. |
| PubMedID- 26140089 | Aim: to evaluate the downstaging rates in hepatitis c virus-patients with hepatocellular carcinoma (hcc), treated with degradable starch microspheres transcatheter arterial chemoembolization (dsm-tace), to reach new-milan-criteria (nmc) for transplantation. |
| PubMedID- 23547582 | Screening for hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 21129375 | Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis c. |
| PubMedID- 26012225 | This study elucidated the role of insulin resistance assessed by the homeostasis model (homa-ir) in development of hepatocellular carcinoma associated with chronic hepatitis c infection. |
| PubMedID- 22419005 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 25559606 | The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection. |
| PubMedID- 22743730 | Case report: a 60 year-old man underwent ldlt for hepatitis c virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 22410057 | The primary liver diseases included hepatitis b virus (n=2), alcoholic liver cirrhosis (n=2), cryptogenic liver disease (n=1), and hepatitis c virus with hepatocellular carcinoma (n=1). |
| PubMedID- 22363173 | We observed a strong correlation between hepatic 8-oxodg staining and serum ferritin levels, suggesting the iron content to be a strong mediator of oxidative stress and iron reduction to reduce the incidence of hepatocellular carcinoma in patients with chronic hepatitis c [57, 58]. |
| PubMedID- 21224684 | We performed transarterial chemoembolization (tace) on the 67-year-old man who had hepatectomy for hepatocellular carcinoma with hepatitis c, recurrence in the liver and lymph nodes.the metastasis in lymph node did not show a clear increase until dying, and tace showed the possibility of one treatment method to the metastasis in lymph node of the hepatocellular carcinoma. |